Important notice

Lindy Capital is a private investment company. It is not open to external investment, and nothing on this website is an offer, invitation, solicitation or advice.Not open to external investment.

Lindy Capital is a private investment vehicle. It invests capital belonging to its own group entities and does not accept, seek or manage money from outside investors. It is not open to external investment, and there is no current intention to open it.

Nothing on this website is an offer, invitation, solicitation or recommendation to invest in Lindy Capital or in any security, fund, property or other financial product. This website does not advertise, promote or offer any financial product or service.

Lindy Capital does not provide financial product advice, investment management or any other financial service to the public, does not hold an Australian Financial Services Licence, and is not a registered managed investment scheme.

Any discussion of investments, holdings or strategy on this site describes Lindy Capital’s own approach and decisions only. It is general in nature, may be out of date, and must not be relied upon as advice or as the basis for any investment decision. Anyone considering an investment should obtain independent professional advice.

Important noticeLindy Capital is a private investment company. It is not open to external investment, and nothing on this website is an offer, invitation, solicitation or advice.Not open to external investment. Nothing here is an offer or advice.Read the full noticeClose notice

Lindy Capital is a private investment vehicle. It invests capital belonging to its own group entities and does not accept, seek or manage money from outside investors. It is not open to external investment, and there is no current intention to open it.

Nothing on this website is an offer, invitation, solicitation or recommendation to invest in Lindy Capital or in any security, fund, property or other financial product. This website does not advertise, promote or offer any financial product or service.

Lindy Capital does not provide financial product advice, investment management or any other financial service to the public, does not hold an Australian Financial Services Licence, and is not a registered managed investment scheme.

Any discussion of investments, holdings or strategy on this site describes Lindy Capital’s own approach and decisions only. It is general in nature, may be out of date, and must not be relied upon as advice or as the basis for any investment decision. Anyone considering an investment should obtain independent professional advice.

Important information page →

Rocket Lab (RKLB) Deep Dive: Rockets, Satellites and a Young Business

A study of Rocket Lab’s launch and space systems business: growth, cash burn, the Neutron delay, the Iridium deal and our fair value estimate.
Rocket Lab (RKLB) deep dive by Lindy Capital

Company in focus

Rocket Lab Corporation

NASDAQ: RKLB

Companies mentioned

Rocket Lab builds small rockets and, increasingly, the satellites and parts that ride on them. Its Electron rocket has flown more than 75 successful missions, and in the quarter to 30 June 2026 the company reported record revenue of US$234.1 million, up 62% on a year earlier, with a contract backlog of US$2.36 billion.

It is also a young, loss-making business at a turning point: its larger Neutron rocket has slipped to 2027, and it has agreed to buy satellite operator Iridium in a deal valued at about US$8 billion. This study looks at durability first, numbers second and price last. It ends with our fair value estimate, none of which is a recommendation.

Rocket Lab at a glance

NASDAQ: RKLB · Long Beach, California · CEO Sir Peter Beck (founder, CEO and chairman) · Fiscal year ends 31 December

Revenue, last 4 quarters
US$769.2M
to 30 June 2026
Revenue growth, latest quarter
62%
Q2 2026 on Q2 2025
Contract backlog
US$2.36B
at 30 June 2026
Free cash flow, last 4 quarters
-US$371M
to 30 June 2026
Net cash
US$2.25B
at 30 June 2026
Market value
US$30.7B
at 19 October 2026 close

Figures as at 19 October 2026 unless stated. Sources are listed at the end of the article. Figures will date.

How we see the business, in one picture

We score five qualities of the business from 1 to 5. This is a judgement about the company, not a rating of its shares. Rocket Lab scores well on its balance sheet after raising more than US$1.5 billion this year, but it has never made an annual profit, its key new rocket has not flown, and as a business it is barely two decades old, so durability and predictability score low.

Lindy business profile: Rocket Lab

Our assessment of business characteristics, scored 1 to 5. Not a rating of the shares or a recommendation.

Competitive advantage (moat)
Moderate
Durability (the Lindy test)
Young and unproven at scale
Financial health
Large cash pile, still burning
Capital allocation
Bold and dilutive
Predictability
Low

Each score is explained in the sections below.

What does Rocket Lab do?

Rocket Lab is an end-to-end space company. It launches satellites, builds satellites, and makes the parts that go inside other companies’ satellites, such as solar panels, reaction wheels (spinning flywheels that point a spacecraft), star trackers and radios.

Founded by Peter Beck in Auckland in 2006, it is now headquartered in Long Beach, California, with launch sites in New Zealand and the United States. It listed on Nasdaq in August 2021 by merging with a special purpose acquisition company (a listed shell), and in May 2025 reorganised so that Rocket Lab Corporation became the listed parent. It reports two segments.

  • Launch Services. Electron, a small rocket for dedicated launches of small satellites, and HASTE, a suborbital version used mainly for US defence hypersonic testing. Neutron, a much larger partly reusable rocket, is in development, with its first launch now expected in 2027.
  • Space Systems. Spacecraft built to order (including satellites for US government constellations), the Photon spacecraft platform, and components sold to other satellite makers. Acquisitions such as SolAero (solar), Geost (sensors), Mynaric (laser communications) and Motiv (robotics) sit here.

The mix has swung firmly towards Space Systems, which supplied 81% of revenue in the June 2026 quarter. Launch is the brand and the long-term bet, but satellites and components now pay most of the bills.

Where the revenue came from, quarter to 30 June 2026

Share of US$234.1M total revenue

81%US$189.5M
19%US$44.6M
Space Systems (US$189.5M)Launch Services (US$44.6M)

Values in US$ billions. Segment revenue from Rocket Lab’s Form 10-Q for the quarter ended 30 June 2026 (Launch Services US$44.586M, Space Systems US$189.480M).

How fast Rocket Lab is growing

Revenue rose from US$62.2 million in 2021 to US$601.8 million in 2025, a compound growth rate of about 76% a year. Some of that came from buying businesses rather than from organic growth, and the base was very small.

Growth has continued in 2026. Revenue for the first half was US$434.4 million, and management guided to US$250 million to US$265 million for the September quarter. Analysts surveyed by StockAnalysis expect about US$958.6 million for 2026, up 59%.

Growth this fast from a small base tells us demand is real, especially from the US government. It does not yet tell us the business can earn a profit at scale.

Rocket Lab annual revenue

US$ millions, fiscal years to 31 December

62
211
245
436
602
959
FY21FY22FY23FY24FY25FY26 est
ReportedAnalyst consensus (StockAnalysis)

Source: StockAnalysis income statement; Rocket Lab FY2025 results. FY26 is analysts’ average estimate, not company guidance.

View the data
Revenue
FY2162
FY22211
FY23245
FY24436
FY25602
FY26 est (estimate)959

The two engines: launch and space systems

Quarterly figures show where growth is coming from. Space Systems revenue roughly doubled from US$97.9 million in the June 2025 quarter to US$189.5 million a year later, helped by satellite programmes for the US government and recent acquisitions.

Launch revenue is lumpier because it depends on how many rockets fly in a quarter. It peaked at US$75.9 million in the December 2025 quarter, then fell to US$44.6 million in June 2026, slightly below a year earlier. Rocket Lab flew 21 Electron and HASTE missions in 2025.

The backlog (contracted work not yet delivered) is the best guide to what comes next. It rose from US$1.10 billion at 30 September 2025 to US$1.85 billion at year end and US$2.36 billion at 30 June 2026. About 45% is expected to turn into revenue within 12 months.

Quarterly revenue by segment

US$ millions; Launch Services and Space Systems

105
132
123
145
155
180
200
234
Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26
Launch ServicesSpace Systems

Series: Launch Services, Space Systems. Source: Rocket Lab Forms 10-Q (Q3 2025, Q2 2026). Q4 24, Q4 25 and Q1 26 are derived by subtracting reported nine-month or six-month totals from full-year (StockAnalysis segment data) or half-year figures.

View the data
Launch ServicesSpace Systems
Q3 242184
Q4 244290
Q1 253687
Q2 254798
Q3 2541114
Q4 2576104
Q1 2664137
Q2 2645190

How Rocket Lab makes money

Launch fees. Customers pay per mission to put a satellite in orbit on Electron or to fly a suborbital test on HASTE. Electron is a dedicated ride, so customers choose the orbit and timing, which supports a higher price per kilogram than sharing a larger rocket.

Building satellites. Rocket Lab is prime contractor on large multi-year satellite contracts, including a US$515 million US government constellation award in 2024 and, in 2026, a US$397 million Space Force contract for spacecraft to launch on Neutron. Revenue is recognised as the work progresses.

Selling components. Solar cells and panels, reaction wheels, star trackers, separation systems, radios and laser communication terminals are sold to other spacecraft makers. This is Rocket Lab’s broadest customer base.

Government work. About 47% of 2025 revenue came from US government-related sources, up from 33% in 2024. One government customer accounted for 42% of revenue in the first half of 2026.

The moat: where the advantage comes from

Rocket Lab’s advantage comes from being one of very few companies that has proved it can reach orbit repeatedly, and from owning most of the parts that go into a satellite. Both are hard and slow to copy, but neither is yet protected by profits.

Sources of competitive advantage

Our assessment of which classic moat sources apply to Rocket Lab

Moat sourceApplies?Where it shows up
Switching costsPartialConstellation customers design around a supplier’s spacecraft bus and components; changing mid-programme is costly
Intangible assetsPartialFlight heritage of 75+ successful Electron missions, US security clearances and launch licences
Network effectsLimitedLittle sign of the business getting more valuable as more customers join
Cost advantage and scaleLimitedVertical integration helps, but SpaceX’s reusable rockets set far lower costs per kilogram
Efficient scalePartialFew credible small launchers and satellite primes exist for US defence work

The moat is real but narrow. Its strongest part is reliability and track record in a market where many rivals have failed to reach orbit. Its weakest point is cost: until Neutron flies and is reused, Rocket Lab cannot match SpaceX on price for most payloads.

Customers and competition

Rocket Lab competes on two fronts: against launch providers for rides to orbit, and against established aerospace firms and start-ups for satellite and component work.

  • SpaceX dominates launch with reusable Falcon 9 rockets and sells cheap shared rides that undercut small rockets for customers who can accept a fixed schedule. It also builds its own Starlink satellites.
  • Firefly Aerospace offers the Alpha small rocket, is developing the Eclipse medium rocket that would compete with Neutron, and builds the Blue Ghost lunar lander.
  • Traditional defence primes and satellite makers compete for US government constellation contracts and in components.

How Rocket Lab compares with its peers

We compare Rocket Lab with SpaceX, the dominant launch company and a listed company since June 2026, and Firefly Aerospace, the closest like-for-like listed rival with both rockets and spacecraft. Both have real revenue, and together they bracket Rocket Lab’s position by size.

Rocket Lab against its closest listed peers

Figures at the close on 19 October 2026. GAAP margins unless stated; forward P/E uses analysts’ next-year earnings estimates.

MeasureRocket Lab
RKLB
SpaceX
SPCX
Firefly Aerospace
FLY
Market valueUS$30.7BUS$2.01TUS$2.8B
Revenue, last 12 monthsUS$769.2MUS$23.0BUS$287.0M
Gross margin37.3%51.9%22.9%
Operating margin (GAAP)-27.6%-14.9%-106.1%
Free cash flow margin-48.3%-141.1%-113.8%
Return on invested capital-5.5%n/a-25.4%
Net cash (net debt)US$2.25BUS$60.3BUS$581.9M
Forward P/ENot meaningful (3,003x)93.3xn/a
PEG ration/an/an/a
Dividend yieldNoneNoneNone

Valuation multiples and market values move with share prices and are shown at the date above. Source: StockAnalysis unless stated.

All three lose money on a GAAP operating basis. Rocket Lab’s operating loss as a share of revenue is smaller than Firefly’s but larger than SpaceX’s, and a higher gross margin than Firefly but lower than SpaceX. Rocket Lab’s free cash flow margin of -48.3% is the least negative of the three, though SpaceX is spending heavily on a far larger base. Free cash flow margins for Rocket Lab, SpaceX and Firefly are our calculations from StockAnalysis free cash flow and revenue.

Durability: the Lindy test

The Lindy effect says the longer something has survived, the longer it is likely to keep surviving. Rocket Lab is 20 years old, has been listed for about five, and reached orbit for the first time in 2018. That is young for an aerospace business, and it scores accordingly.

Key moments in Rocket Lab’s history

  • 2006 · Peter Beck founds Rocket Lab in Auckland, New Zealand.
  • 2009 · The Ātea-1 sounding rocket reaches space, a first for a private company in the Southern Hemisphere.
  • 2018 · Electron reaches orbit on its second flight, after a first flight in 2017 that failed.
  • 2020 · Headquarters moves to Long Beach, California; the first Photon spacecraft flies; an Electron failure loses customer payloads.
  • 2021 · Lists on Nasdaq through a SPAC merger; announces Neutron; a second Electron failure.
  • 2022 · Buys SolAero; the CAPSTONE mission reaches lunar orbit with help from Photon.
  • 2023 · First HASTE mission; a third Electron failure; a record 10 Electron flights that year.
  • 2025 · Rocket Lab Corporation becomes the listed parent; Geost acquired; 21 missions flown with 100% success.
  • 2026 · Mynaric and Motiv acquired; Iridium deal agreed; Neutron’s first launch moved to 2027.

Three launch failures in 2020, 2021 and 2023 were each followed by a return to flight, which is a sign of resilience. But the business has never earned an annual profit and its next stage depends on a rocket that has not yet flown, so on the Lindy test it remains early.

Profitability and cash flow

Gross margin, what is left after the direct cost of products and services, improved from 32.1% in the June 2025 quarter to 36.1% a year later. Guidance for the September 2026 quarter is lower, at 29% to 31%, as new programmes ramp.

Operating losses have barely shrunk in dollars: US$57.5 million in the June 2026 quarter against US$59.6 million a year earlier, because research and development on Neutron and new programmes keeps rising. The company is near breakeven on adjusted EBITDA, a measure that excludes share-based pay and other items, at a loss of US$8.8 million for the quarter.

Free cash flow, operating cash flow less capital spending, has been negative every year. It was -US$321.8 million in 2025 and -US$187.5 million in the first half of 2026.

Annual free cash flow

US$ millions

−98
−149
−154
−116
−322
−371
FY21FY22FY23FY24FY25TTM Jun 26

US$ millions. Source: StockAnalysis cash flow statement; operating cash flow less capital expenditures.

View the data
Value
FY21−98
FY22−149
FY23−154
FY24−116
FY25−322
TTM Jun 26−371

Losses are partly a choice: the company is funding Neutron and new launch sites. The test is whether margins rise once Neutron is flying and the large satellite contracts mature.

Financial health: debt and cash

At 30 June 2026 Rocket Lab held US$2.13 billion in cash plus US$258.1 million in marketable securities, about US$2.39 billion in total. Convertible notes on the balance sheet fell from US$152.4 million at the end of 2025 to US$13.1 million, plus US$1.7 million of other borrowings.

StockAnalysis puts net cash, after leases and other debt, at US$2.25 billion. That cash came largely from selling new shares: about US$1.53 billion was raised through at-the-market share sales in the first half of 2026.

The balance sheet is strong for today, but it will change if the Iridium deal closes. Rocket Lab has committed financing for a US$3.6 billion bridge loan to fund the cash part of the purchase, which would turn a net cash position into meaningful debt.

Capital allocation and management

Peter Beck founded the company and still leads it as chief executive and chairman, which gives continuity and a clear engineering culture. The flip side is a long record of ambitious timelines: Neutron was once planned for 2025 and is now expected in 2027.

Management has used its highly valued shares as currency, raising cash through share sales and buying a string of component makers. The share count rose from 543.6 million common shares at the end of 2025 to 598.2 million at 30 June 2026. The Iridium deal, at US$27 cash plus Rocket Lab shares for each Iridium share, is the largest step yet and would add both debt and further dilution.

Strengths and risks at a glance

What stands out

Our checklist of the business’s main strengths and risks

Strengths
  • Proven launch record: more than 75 successful Electron missions and 21 missions in 2025 without a failure.
  • Record backlog of US$2.36 billion at 30 June 2026, up 137% on a year earlier.
  • Vertical integration across rockets, spacecraft and components.
  • Net cash of about US$2.25 billion to fund development.
  • Deep ties with US government and defence customers, with HASTE serving hypersonic testing.
Risks
  • Neutron has slipped again, to 2027, after a tank problem; further delays would push out the growth case.
  • No annual profit to date and negative free cash flow every year.
  • Heavy reliance on US government spending; one customer was 42% of first-half 2026 revenue.
  • The Iridium deal would add a US$3.6 billion bridge loan, new shares and integration risk.
  • SpaceX’s scale and reusable rockets set the price for much of the market.

The case for and against the business

Both sides

The strongest arguments we can make each way about the business

The case for

Rocket Lab has done what most launch start-ups could not: it reaches orbit reliably and has built a satellite and component business that now earns most of its revenue. Backlog more than doubled in a year, gross margins have improved, and the company has the cash to finish Neutron. If Neutron works and is reused, Rocket Lab could become the main US alternative to SpaceX for medium payloads, with Iridium adding recurring service revenue.

The case against

The company is still losing money and burning cash, and its growth story depends on a rocket that has been delayed repeatedly. Much of its revenue comes from one government customer and from acquisitions funded with dilutive share sales. The Iridium deal adds debt and complexity at the same time Neutron is unproven, and SpaceX remains far larger and cheaper.

Our fair value estimate for Rocket Lab

Because Rocket Lab is not profitable, we value it on enterprise value to sales: the value of the operating business as a multiple of revenue. We take analysts’ 2027 revenue estimate of US$1.33 billion (StockAnalysis), apply a haircut for Neutron and execution risk, multiply by a sales multiple, add net cash we expect at the end of 2027 after further cash burn, divide by about 641 million shares (including preferred stock) and discount back 1.2 years at 12% a year. We value Rocket Lab on its own and leave the Iridium deal out, since it has not closed.

Our base case uses US$1.20 billion of 2027 revenue (a 10% haircut), 12 times sales and US$1.85 billion of net cash, giving about US$22 a share today. The bear case gives about US$10 and the bull case about US$48, against a share price of US$51.36. The current price implies a sales multiple well above our bull case; this is our estimate and may prove wrong.

Lindy Capital fair value estimate · Rocket Lab Corporation

Overvalued on our estimate

Our fair value estimateUS$22Range US$10 to US$48
Share priceUS$53.61Close, 18 November 2026
Difference+142%above our estimate

The share price is 142% above our fair value estimate. Shaded bands sit 20% either side of our base-case estimate; the striped strip shows the range of our scenarios.

ScenarioFY2027 revenueEV/sales appliedFair value today
Bear: 25% haircut, US$1.45B net cash, 680M sharesUS$1.00B6xUS$9.56
Base: 10% haircut, US$1.85B net cash, 641M sharesUS$1.20B12xUS$22.13
Bull: consensus, US$2.05B net cash, 641M sharesUS$1.33B25xUS$48.07

Fair value = (FY2027 revenue × EV/sales + expected net cash at end-2027) ÷ shares, discounted 1.2 years at 12%; revenue anchor is StockAnalysis consensus, net cash starts from US$2.25B at 30 June 2026.

Two traps when valuing Rocket Lab

Trailing sales multiples flatter the future. At about 37 times trailing sales, the price already assumes years of fast growth and a working Neutron. A slip in either can compress the multiple quickly, as the fall from a 52-week high of about US$151 shows.

The share count is a moving target. Share sales, conversions and the stock portion of the Iridium deal (up to 0.4 Rocket Lab shares per Iridium share) can all raise the share count, so per-share value can fall even if the business grows.

Share price vs our fair value estimate

Weekly closing price over two years, with each fair value estimate from the date we published it. The shaded band is our bear-to-bull range.

US$151US$80US$9
Fair value US$22
Nov 2024Nov 2026
Share price (weekly close)Our fair value estimateBear-to-bull range

First estimate published 5 November 2026. The dashed line shows the estimate in force; until we revise it, it is drawn across the whole period for comparison. Latest weekly price US$53.60. Prices from Yahoo Finance, refreshed daily. The estimate changes only when we revise it.

What we would watch

  • A firm date for Neutron’s first launch and its outcome.
  • Progress on the Iridium deal: regulatory approvals, final financing and share issuance.
  • Gross margin against the 29% to 31% GAAP guidance for the September 2026 quarter.
  • Backlog growth and how much converts to revenue within 12 months.
  • Free cash flow and any further share sales.

The short version

Rocket Lab is a real, growing space business with a proven small rocket, a fast-growing satellite arm and a strong cash position. It is also young, unprofitable and dependent on a delayed rocket and a large pending acquisition. Our base-case fair value of about US$22 a share is well below the current price, which reflects how much success the market already assumes. It is an opinion, not advice.

Frequently asked questions

What does Rocket Lab do?

It launches small satellites on its Electron rocket, flies suborbital tests on HASTE, and builds satellites and spacecraft components. Space Systems supplied 81% of revenue in the June 2026 quarter.

Is Rocket Lab profitable?

No. It reported a net loss of US$165.5 million over the 12 months to 30 June 2026 and has had negative free cash flow every year since listing.

When will Neutron launch?

On 14 October 2026 Rocket Lab said Neutron’s first launch is now expected in 2027, later than its previous target of the fourth quarter of 2026.

Why is Rocket Lab buying Iridium?

Iridium operates a global satellite communications network. The deal, valued at about US$8 billion including debt, would add recurring service revenue and spectrum. It is expected to close in 2027, subject to approvals.

Is Rocket Lab a buy?

We don’t make buy or sell recommendations. Our fair value estimate, set out above with its assumptions, is our opinion of what the business may be worth, not advice. Whether any investment suits you depends on your own circumstances, so speak to a licensed financial adviser.

Sources

Disclosure: Lindy Capital may hold, buy or sell shares in Rocket Lab (RKLB) at any time, without notice, and does not disclose its positions. This is a study of how a business works, not a recommendation to buy, sell or hold any security. Our fair value estimate is an opinion based on the assumptions stated with it, not a price target or a forecast of the share price. Company guidance and analysts’ estimates are shown as reported. Figures are from public filings and data providers and will date. Important information.